Long
80% Mapped for Humaniq (HMQ)
Here we have Humaniq (HMQBTC), a low volume altcoin trading pair.
With a recent break of resistance, in the form of a descending trendline and EMAs, we can expect additional growth.
The next target is marked here at 45% from the current price and up to 84% on a strong jump.
These targets can be hit easy... Just as we saw with the other altcoins that I shared before.
Remember to hit LIKE, FOLLOW, and leave a comment, if you would like to show your support.
Namaste.
With a recent break of resistance, in the form of a descending trendline and EMAs, we can expect additional growth.
The next target is marked here at 45% from the current price and up to 84% on a strong jump.
These targets can be hit easy... Just as we saw with the other altcoins that I shared before.
Remember to hit LIKE, FOLLOW, and leave a comment, if you would like to show your support.
Namaste.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.